Cargando…

Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant

Patients with chronic lymphocytic leukemia (CLL) who progress to Richter transformation (RT) have a poor prognosis. Multi-agent chemotherapy regimens do not have good response rates. There are few case reports on the use of ibrutinib in RT. Here, we present a patient who was heavily pretreated for C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Master, Samip, Leary, Cheri, Takalkar, Amol, Coltelingam, James, Mansour, Richard, Mills, Glenn M., Koshy, Nebu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498945/ https://www.ncbi.nlm.nih.gov/pubmed/28690529 http://dx.doi.org/10.1159/000477338

Ejemplares similares

Use of Eltrombopag in Improving Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
por: Master, Samip, et al.
Publicado: (2018)

Allogeneic hematopoietic cell transplantation outcomes in patients with Richter’s transformation
por: Kim, Haesook T., et al.
Publicado: (2021)

Ibrutinib has some activity in Richter's syndrome
por: Giri, S, et al.
Publicado: (2015)

An Approach to Diagnosis of Richter Transformation in Chronic Lymphocytic Leukemia
por: Broadway-Duren, Jackie
Publicado: (2022)

Hodgkin's variant of Richter transformation during ibrutinib therapy: A case report and review of the literature
por: Afonso, Carolina, et al.
Publicado: (2022)

Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
por: Nadeu, Ferran, et al.
Publicado: (2022)

Treatment of Richter Transformation of Chronic Lymphocytic Leukemia in the Modern Era
por: Briski, Robert, et al.
Publicado: (2023)

Ibrutinib and rituximab induced rapid response in refractory Richter syndrome
por: Lamar, Zanetta, et al.
Publicado: (2015)

Dasatinib-Induced Rhabdomyolysis in a 33-Year-Old Patient with Chronic Myeloid Leukemia
por: Joel Chandranesan, Andrew Stevenson, et al.
Publicado: (2018)

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies
por: Pflug, Natali, et al.
Publicado: (2021)

Excellent response to chemotherapy post immunotherapy
por: Dwary, Ashish D., et al.
Publicado: (2017)

Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome
por: Fabbri, Giulia, et al.
Publicado: (2013)

Secondary Hemophagocytic Syndrome Associated with Richter's Transformation in Chronic Lymphocytic Leukemia
por: El-Haj, Nura, et al.
Publicado: (2014)

Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents
por: Tadmor, Tamar, et al.
Publicado: (2021)

An experience with ibrutinib monotherapy for Richter’s syndrome isolated in the central nervous system
por: Nato, Yuma, et al.
Publicado: (2022)

Rare Richter Transformation of Chronic Lymphocytic Lymphoma to Hodgkin Lymphoma
por: Buckley, Tinera, et al.
Publicado: (2021)

Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia
por: Tam, Constantine, et al.
Publicado: (2023)

Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation
por: Hodkinson, Brendan P., et al.
Publicado: (2020)

A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL
por: Jain, Nitin, et al.
Publicado: (2022)

Biology and Treatment of Richter Transformation
por: Condoluci, Adalgisa, et al.
Publicado: (2022)

Cytogenomic features of Richter transformation
por: Woroniecka, Renata, et al.
Publicado: (2023)

Results of ARI-0001 CART19 Cells in Patients With Chronic Lymphocytic Leukemia and Richter’s Transformation
por: Ortiz-Maldonado, Valentín, et al.
Publicado: (2022)

The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation
por: Visentin, Andrea, et al.
Publicado: (2021)

Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter’s transformation
por: Hing, Zachary A., et al.
Publicado: (2023)

A Carotid Body Tumour Mimicking Richter’s Transformation of Chronic Lymphocytic Leukaemia
por: Qamar, Younus, et al.
Publicado: (2022)

Cellular Therapies in Chronic Lymphocytic Leukemia and Richter’s Transformation: Recent Developments in Chimeric Antigen Receptor T-Cells, Natural Killer Cells, and Allogeneic Stem Cell Transplant
por: Coombs, Catherine C., et al.
Publicado: (2023)

Allogeneic hematopoietic cell transplantation is an effective treatment for patients with Richter syndrome: A systematic review and meta-analysis
por: Aulakh, Sonikpreet, et al.
Publicado: (2020)

PB1881: IBRUTINIB REDUCES THE RISK OF RICHTER’S TRANSFORMATION IN PREVIOUSLY TREATED CLL PATIENTS: A POPULATION-BASED STUDY IN BRITISH COLUMBIA
por: Ramadan, R., et al.
Publicado: (2022)

Herpes Simplex Necrotic Lymphadenitis Masquerading as Richter’s Transformation in Treatment-Naive Patients With Chronic Lymphocytic Leukemia
por: Hodgson, Yan Amber, et al.
Publicado: (2019)

Hodgkin Variant of Richter’s Transformation in Chronic Lymphocytic Leukemia (CLL): An Illustrative Case Report and Literature Review
por: Gupta, Nishit, et al.
Publicado: (2021)

Long-term effect of venetoclax therapy in a patient with the transformation of chronic lymphocytic leukemia into Richter’s syndrome
por: Tutaeva, Victoria Vladimirovna, et al.
Publicado: (2022)

Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
por: Wang, Yucai, et al.
Publicado: (2021)

Richter Transformation: Clinical Manifestations, Evaluation, and Management
por: Douglas, Melanie
Publicado: (2022)

A Systematic Review on the Prevention and Control of Opportunistic Infections in Patients With Chronic Lymphocytic Leukemia Complicated by Richter’s Transformation
por: Arzoun, Hadia, et al.
Publicado: (2022)

Correction to: Long-term effect of venetoclax therapy in a patient with the transformation of chronic lymphocytic leukemia into Richter’s syndrome
Publicado: (2023)

Ibrutinib Induces a Dramatic Improvement for Idiopathic Refractory Ascites Following Allogeneic Hematopoietic Cell Transplantation
por: Tazoe, Kumiyo, et al.
Publicado: (2023)

Hodgkin's lymphoma as a rare variant of Richter's transformation in chronic lymphocytic leukemia: A case report and review of the literature
por: JANJETOVIC, SNJEZANA, et al.
Publicado: (2016)

Richter Transformation of Chronic Lymphocytic Leukemia: A Review of Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography and Molecular Diagnostics
por: Shaikh, Faiq, et al.
Publicado: (2017)

High-grade B-Cell lymphoma with MYC and BCL6 rearrangements associated with Richter transformation of chronic lymphocytic leukemia
por: Rogers, Thomas S, et al.
Publicado: (2019)

Tumor Lysis Syndrome Caused by Unrecognized Richter’s Transformation of Chronic Lymphocytic Leukemia: Treatment With Venetoclax for Suspected Disease Progression
por: Chango Azanza, Juan Jose, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o9f6lp6n03k3hf01q60gd2je2c